TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+/CD23- B Cell Follicles Is Prevented with Anti-TNF Therapy

被引:25
作者
Wu, Emily K. [1 ,2 ]
Henkes, Zoe I. [2 ]
McGowan, Brion [2 ]
Bell, Richard D. [2 ,3 ]
Velez, Moises J. [3 ]
Livingstone, Alexandra M. [1 ,4 ]
Ritchlin, Christopher T. [5 ]
Schwarz, Edward M. [1 ,2 ,6 ]
Rahimi, Homaira [2 ,7 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA
[4] Univ Rochester, Sch Med & Dent, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA
[5] Univ Rochester, Sch Med & Dent, Dept Med, Allergy Immunol & Rheumatol, Rochester, NY 14642 USA
[6] Univ Rochester, Sch Med & Dent, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA
[7] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA
基金
美国国家卫生研究院;
关键词
TUMOR-NECROSIS-FACTOR; TRANSGENIC MOUSE MODEL; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; PULMONARY-FIBROSIS; LYMPHATIC VESSELS; MORTALITY; PNEUMONIA; MICE; OVEREXPRESSION;
D O I
10.4049/jimmunol.1900473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interstitial lung disease (ILD) is a well-known extra-articular manifestation of rheumatoid arthritis (RA). RA-associated ILD (RA-ILD) exists on a wide spectrum, with variable levels of inflammatory and fibrotic activity, although all subtypes are regarded as irreversible pathologic conditions. In both articular and pulmonary manifestations, TNF is a significant pathogenic factor. Whereas anti-TNF therapy alleviates joint pathologic conditions, it exacerbates fibrotic RA-ILD. The TNF-transgenic (TNF-Tg) murine model of RA develops both inflammatory arthritis and an ILD that mimics a cellular nonspecific interstitial pneumonia pattern dominated by an interstitial accumulation of inflammatory cells with minimal-to-absent fibrosis. Given the model's potential to elucidate the genesis of inflammatory RA-ILD, we aim to achieve the following: 1) characterize the cellular accumulations in TNF-Tg lungs, and 2) assess the reversibility of inflammatory ILD following anti-TNF therapy known to resolve TNF-Tg inflammatory arthritis. TNF-Tg mice with established disease were randomized to anti-TNF or placebo therapy and evaluated with imaging, histology, and flow cytometric analyses, together with wild-type controls. Flow cytometry of TNF-Tg versus wildtype lungs revealed significant increases in activated monocytes, conventional dendritic cells, and CD21(+)/CD23(-) B cells that are phenotypically distinct from the B cells in inflamed nodes, which are known to accumulate in joint-draining lymph nodes. In contrast to human RA-ILD, anti-TNF treatment significantly alleviated both joint and lung inflammation. These results identify a potential role for activated monocytes, conventional dendritic cells, and CD21(+)/CD23(-) B cells in the genesis of RA-ILD, which exist in a previously unknown, reversible, prefibrotic stage of the disease.
引用
收藏
页码:2837 / 2849
页数:13
相关论文
共 81 条
[81]   Patterns of interstitial lung disease and mortality in rheumatoid arthritis [J].
Zamora-Legoff, Jorge A. ;
Krause, Megan L. ;
Crowson, Cynthia S. ;
Ryu, Jay H. ;
Matteson, Eric L. .
RHEUMATOLOGY, 2017, 56 (03) :344-350